|1.||Calonge, Margarita: 5 articles (01/2016 - 09/2007)|
|2.||González-García, María J: 4 articles (01/2016 - 10/2012)|
|3.||Maruo, Takeshi: 4 articles (02/2005 - 08/2002)|
|4.||López-Miguel, Alberto: 3 articles (01/2016 - 04/2014)|
|5.||Stern, Michael E: 3 articles (01/2016 - 09/2007)|
|6.||Tesón, Marisa: 3 articles (01/2016 - 04/2014)|
|7.||Matsuo, Hiroya: 3 articles (02/2005 - 08/2002)|
|8.||Martín-Montañez, Vicente: 2 articles (01/2016 - 04/2014)|
|9.||Enríquez-de-Salamanca, Amalia: 2 articles (01/2016 - 04/2014)|
|10.||Ge, Yuebin: 2 articles (01/2015 - 12/2009)|
05/01/2015 - "The mixture of HH and RC extracts in a 1:1 concentration at a dose of 200 mg/kg showed a more potent effect on phenol red secretion (25.25±3.14) and cough inhibition (61.25±5.36) than the individual use of each extracts [phenol red secretion; HH 13.39±4.22 (p=0.000), RC 20.78±2.50 (p=0.010), cough inhibition; HH 9.89±4.14 (p=0.010), RC 30.25±7.69 (p=0.000)]. "
07/01/2013 - "According to a regression analysis, Pinelliae Rhizoma and Aconiti Radix Cocta had the synergistic effect in the secretion of phenol red in tracheas, which was maximized with a total dose of more than 5 g x kg(-1) and a ratio of 1: 1. The compatible application of Pinelliae Rhizoma and Aconiti Radix Cocta can decrease the analgesic and anti-inflammatory effects of Aconiti Radix Cocta and promote the cough-relieving effect of Pinelliae Rhizoma, which vary according to different matching ratio and dose. "
07/01/2013 - "The combined decoction could effectively increase the secretion of phenol red in tracheas and decrease the frequency of coughs. "
07/01/2013 - "(2) The effect on the secretion of phenol red in tracheas and frequency of coughs. "
06/01/2013 - "Both doses of BP also significantly reduced the bouts of cough but only 400 mg/kg/day significantly inhibited the amount of phenol red secreted. "
|2.||Breast Neoplasms (Breast Cancer)
01/01/2012 - "MCF-7, human breast cancer cells, were cultured in phenol red-free DMEM and treated with 1 nM 2-OH-E2 or 4-OH-E2. "
08/01/2000 - "Human endometrial (Ishikawa, Hec-1A), ovarian (EFO-21, EFO-27, SK-OV-3), and breast cancer cell lines (MCF-7) were rendered quiescent by incubation (72 h) in the absence of fetal calf serum and phenol red. "
07/01/2000 - "Fourth, we asked if phenol red displaced the binding of 3H-E2 using ERK intact human breast cancer cells. "
06/05/1999 - "We grew breast cancer cells (MCF-7, T-47D, ZR-75-1) known to proliferate under estrogenic stimulation in phenol red-free DMEM containing human serum and concentrations of BPA or BPA-DM ranging from 10(-8)M to 5 x 10(-6)M. "
05/01/1992 - "Growth factor-like activity of phenol red preparations in the MCF-7 breast cancer cell line."
10/01/1996 - "We quantified the recovery of Phenol Red (model drug) in the tumor, leakage from the tumor surface and the venous outflow after intratumoral injection using perfused tissue-isolated tumors, and analyzed venous appearance curves based on a pharmacokinetic model in which the tumor tissue was assumed to be divided into two compartments, i.e., well- and poorly-perfused regions. "
12/01/1949 - "The binding of phenolsulfonphthalein by serum and by albumin isolated from serum in cancer."
01/01/1959 - "[Results of kidney function tests with phenolsulfonphthalein in patients with malignant genital tumors especially cervical and uterine carcinomas]."
07/01/1991 - "In serum-free, estradiol-free, phenol-red-free chemically defined medium (Cancer Res 1984; 44: 4553), IFN gamma abolished in ZR75-1 but not in T47D the 30% growth stimulation induced by estradiol. "
05/01/2008 - "Drug release kinetics from the PLGA coating was examined using phenol red (PhR, a hydrophilic dye) and carmustine (BCNU, a hydrophobic anti-tumor agent) as model drugs. "
06/01/1983 - "However, the urinary recovery of phenol red after its intravenous administration was not affected by the ulcers. "
07/01/1984 - "The urinary recovery after oral administration of phenol red and the ulcer index of the stomach were significantly increased in rats subjected to restraint and water immersion stress. "
06/01/1982 - "An assessment of gastrointestinal mucosal damage in vivo: enhancement of urinary recovery after oral administration of phenolsulfonphthalein in ulcer rats."
03/01/1965 - "[Comparative studies on phenol red excretion in patients with ulcer of the stomach and duodenum, 6 months after partial gastrectomy]."
01/01/1995 - "Before the trial and every 3 or 4 weeks, phenol red dye spraying endoscopy, the rapid urease test, biopsy specimen histology, and culture were performed to assess the ulcer stage and to detect Hp. "
01/01/1989 - "Acidification to pH 2 resulted in a slightly but significantly reduced excretion of phenol red, lowered proteinuria and a decreased urine volume, whereas all other parameters remained unchanged. "
01/01/1964 - "[THE ALTERATION OF CREATINE CLEARANCE, PROTEINURIA, ELECTROLYTE AND PHENOL RED EXCRETION IN CHRONIC NEPHRITIS BY ORTHOSTASIS]."
10/01/1986 - "Seeking to study whether measurement of lysozyme (EC 188.8.131.52) in urine by a reliable radioimmunoassay can provide a suitable index of renal tubular function and how lysozymuria develops in temporal relation to proteinuria in diabetic nephropathy, we have compared the urinary excretion of lysozyme and beta 2-microglobulin with the 15-min excretion rate of phenolsulfonphthalein in 39 patients with Type 2 (non-insulin-dependent) diabetes and investigated the temporal relation between the onset of lysozymuria and proteinuria in 15 patients with Type 1 (insulin-dependent) diabetes. "
|3.||Acetic Acid (Vinegar)
|8.||Ethanol (Ethyl Alcohol)